Should there be different ovarian cancer treatment strategies based on BRCA1 and BRCA2?

被引：0
|
作者：
Harrison, Natalie
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2011年 / 11卷 / 12期
关键词：
D O I：
10.1586/ERA.11.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1787 / 1787
页数：1
相关论文
共 50 条
  • [1] Should there be different ovarian cancer treatment strategies based on BRCA1 and BRCA2?
    Harrison, Natalie
    PHARMACOGENOMICS, 2011, 12 (12) : 1633 - 1634
  • [2] The Contribution of BRCA1 and BRCA2 to Ovarian Cancer
    Ramus, Susan J.
    Gayther, Simon A.
    MOLECULAR ONCOLOGY, 2009, 3 (02) : 138 - 150
  • [3] Inactivation of BRCA1 and BRCA2 in ovarian cancer
    Hilton, JL
    Geisler, JP
    Rathe, JA
    Hattermann-Zogg, MA
    DeYoung, B
    Buller, RE
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (18): : 1396 - 1406
  • [4] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
  • [5] BRCA1 and BRCA2 Mutations in Ovarian Cancer Reply
    Zhang, Wei
    Yang, Da
    Sood, Anil K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 360 - 361
  • [6] BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
    Welcsh, PL
    King, MC
    HUMAN MOLECULAR GENETICS, 2001, 10 (07) : 705 - 713
  • [7] BRCA1 and BRCA2 as ovarian cancer susceptibility genes
    Sowter, HM
    Ashworth, A
    CARCINOGENESIS, 2005, 26 (10) : 1651 - 1656
  • [8] Surgical treatment in ovarian cancer prevention in carriers of the BRCA1/BRCA2 mutation
    Synowiec, Agnieszka
    Wcislo, Gabriel
    Bodnar, Lubomir
    Szczylik, Cezary
    GINEKOLOGIA POLSKA, 2012, 83 (01) : 51 - 56
  • [9] Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer
    Wenham, RM
    Schildkraut, JM
    McLean, K
    Calingaert, B
    Bentley, RC
    Marks, J
    Berchuck, A
    CLINICAL CANCER RESEARCH, 2003, 9 (12) : 4396 - 4403
  • [10] Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations
    Ganguly, Shuvadeep
    Gogia, Ajay
    LANCET ONCOLOGY, 2022, 23 (07): : E314 - E314
12345